The Radiotherapy, Proton Therapy, and Brachytherapy Market
The most common type of radiation therapy is external beam radiation, which involves a machine that directs high-energy beams of radiation at cancer cells. The machine allows radiation to be targeted at specific sites, which is why external beam radiation is used for nearly all types of cancer. An alternative treatment modality to radiotherapy is proton therapy, also known as charged particle radiotherapy. Instead of photons, proton therapy uses beams of protons or other charged particles, such as helium, carbon, or other ions. Brachytherapy is also a form of radiation therapy where a sealed radiation source is placed inside or next to the area requiring treatment. Brachytherapy is often used for cancers of the prostate, liver, and breast. Radiation therapy works by making small breaks in the DNA inside cells, and these breaks keep cancer cells from growing and dividing. Adjacent normal cells can also be affected by radiation, but most recover and go back to working normally.Â
This report covers a global radiotherapy, proton therapy, and brachytherapy market and includes details on specific equipment sales as well as associated accessories, consumables, and services. This report also features regional analysis as well as country-level analysis for key markets.
THE PROBLEM
The top five companies in the radiation therapy market currently comprise most revenues. But there is a significant amount of unmet demand which means opportunity for both the large internationals as well as regional vendors. However, identifying these opportunities can be a challenge—particularly without up-to-date information on contracts, contract winners, discounts and prices, and forecasted tenders in the global healthcare markets.
BENEFITS
Drive strategy with regularly updated datasets.
Identify which product markets hold the most opportunity.
Gain insight into competitive positioning.
Visualize the comprehensive global market or drill down into product-level detail.
Contact